PODD Insulet Corp

Price (delayed)

$290.30

Market cap

$19.14B

P/E Ratio

645.11

Dividend/share

N/A

EPS

$0.45

Enterprise value

$19.22B

Sector: Healthcare
Industry: Medical Devices

Highlights

PODD's net income has surged by 75% year-on-year and by 60% since the previous quarter
The EPS has soared by 67% YoY and by 61% from the previous quarter
Insulet's quick ratio has decreased by 18% from the previous quarter and by 7% YoY
Insulet's gross margin has decreased by 2.7% YoY

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
65.93M
Market cap
$19.14B
Enterprise value
$19.22B
Valuations
Price to earnings (P/E)
645.11
Price to book (P/B)
32.03
Price to sales (P/S)
21.99
EV/EBIT
244.7
EV/EBITDA
163.77
EV/Sales
22.15
Earnings
Revenue
$867.69M
EBIT
$78.56M
EBITDA
$117.37M
Free cash flow
-$5.68M
Per share
EPS
$0.45
Free cash flow per share
-$0.09
Book value per share
$9.06
Revenue per share
$13.2
TBVPS
$25.27
Balance sheet
Total assets
$1.71B
Total liabilities
$1.12B
Debt
$921.5M
Equity
$595M
Working capital
$985.2M
Liquidity
Debt to equity
1.55
Current ratio
6.62
Quick ratio
5.61
Net debt/EBITDA
0.71
Margins
EBITDA margin
13.5%
Gross margin
64%
Net margin
3.3%
Operating margin
8.9%
Efficiency
Return on assets
2.1%
Return on equity
8.9%
Return on invested capital
4.9%
Return on capital employed
5.1%
Return on sales
9.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
-0.11%
1 week
3.24%
1 month
14.08%
1 year
51.83%
YTD
13.56%
QTD
13.56%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$867.69M
Gross profit
$555.31M
Operating income
$76.93M
Net income
$28.87M
Gross margin
64%
Net margin
3.3%
PODD's net income has surged by 75% year-on-year and by 60% since the previous quarter
Insulet's operating income has surged by 60% YoY and by 10% QoQ
The company's net margin has surged by 50% QoQ and by 38% YoY
The company's operating margin rose by 29% YoY and by 4.7% QoQ

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
P/E
645.11
P/B
32.03
P/S
21.99
EV/EBIT
244.7
EV/EBITDA
163.77
EV/Sales
22.15
The EPS has soared by 67% YoY and by 61% from the previous quarter
PODD's price to earnings (P/E) is 38% lower than its last 4 quarters average of 1047.9
PODD's price to book (P/B) is 65% less than its last 4 quarters average of 91.0 and 36% less than its 5-year quarterly average of 50.2
The equity is up by 6% QoQ
PODD's price to sales (P/S) is 120% higher than its 5-year quarterly average of 10.0 and 46% higher than its last 4 quarters average of 15.1
PODD's revenue is up by 25% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Insulet business performance
Insulet's return on invested capital has surged by 53% YoY and by 26% QoQ
The return on assets has surged by 50% since the previous quarter and by 31% year-on-year
The ROS has grown by 44% YoY and by 20% from the previous quarter
PODD's ROE is up by 13% YoY and by 4.7% QoQ

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 53% higher than the total liabilities
The total assets rose by 35% YoY and by 5% QoQ
Insulet's quick ratio has decreased by 18% from the previous quarter and by 7% YoY
The company's debt is 55% higher than its equity
The debt to equity has plunged by 76% YoY and by 4.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.